Prednisolone farnesylate (PNF21) is a new transdermal corticosteroid with anti-inflammatory activity. In Vitro: Prednisolone farnesylate is a synthetic glucocorticoid, which is a compound of Prednisolone and its ester Farnesylate and is known to suppress local swelling of the adjuvant-induced arthritis^[1].